Metabolix PE Ratio 2010-2024 | YTEN
Current and historical p/e ratio for Metabolix (YTEN) from 2010 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Metabolix PE ratio as of November 07, 2024 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
Metabolix PE Ratio Historical Data |
Date |
Stock Price |
TTM Net EPS |
PE Ratio |
2024-09-30 |
1.05 |
|
0.00 |
2024-03-31 |
9.12 |
$-36.42 |
0.00 |
2023-12-31 |
5.74 |
$-49.88 |
0.00 |
2023-09-30 |
7.84 |
$-59.47 |
0.00 |
2023-06-30 |
53.28 |
$-66.67 |
0.00 |
2023-03-31 |
66.24 |
$-68.11 |
0.00 |
2022-12-31 |
40.07 |
$-66.19 |
0.00 |
2022-09-30 |
71.76 |
$-64.75 |
0.00 |
2022-06-30 |
54.00 |
$-59.47 |
0.00 |
2022-03-31 |
127.20 |
$-58.03 |
0.00 |
2021-12-31 |
118.08 |
$-56.12 |
0.00 |
2021-09-30 |
143.76 |
$-60.43 |
0.00 |
2021-06-30 |
204.72 |
$-69.54 |
0.00 |
2021-03-31 |
300.96 |
$-76.26 |
0.00 |
2020-12-31 |
138.72 |
$-112.71 |
0.00 |
2020-09-30 |
186.48 |
$-382.01 |
0.00 |
2020-06-30 |
150.24 |
$-514.63 |
0.00 |
2020-03-31 |
90.48 |
$-636.45 |
0.00 |
2019-12-31 |
164.64 |
$-796.64 |
0.00 |
2019-09-30 |
481.92 |
$-690.65 |
0.00 |
2019-06-30 |
930.05 |
$-786.57 |
0.00 |
2019-03-31 |
1094.40 |
$-872.90 |
0.00 |
2018-12-31 |
796.80 |
$-892.09 |
0.00 |
2018-09-30 |
1382.40 |
$-1,659.47 |
0.00 |
2018-06-30 |
1353.60 |
$-1,976.02 |
0.00 |
2018-03-31 |
1872.00 |
$-2,417.27 |
0.00 |
2017-12-31 |
1699.20 |
$-3,107.91 |
0.00 |
Sector |
Industry |
Market Cap |
Revenue |
Consumer Staples |
Agricultural Operations |
$0.000B |
$0.000B |
Yield10 Bioscience, Inc. is an agricultural bioscience company. It focuses on the development of disruptive technologies for improvement in crop yield to enhance global food security. The company is working on new approaches, to improve fundamental elements of plant photosynthetic efficiency and optimizing carbon metabolism for better production. It operates primarily in Saskatoon, Saskatchewan, Canada. Yield10 Bioscience, Inc., formerly known as Metabolix, Inc., is based in Woburn, Massachusetts.
|